By Devika Patel
Knoxville, Tenn., Aug. 14 – Ironshore Pharmaceuticals & Development, Inc. said it arranged a $143 million senior secured notes offering.
The notes priced at 98.
Morgan Stanley & Co. LLC was the agent.
Proceeds will be used to support the launch of Jornay PM and fund the costs of all planned commercialization and marketing initiatives, with the launch of the drug projected to occur in the first half of 2019.
The subsidiary of Highland Therapeutics is based in the Cayman Islands.
| Issuer: | Ironshore Pharmaceuticals & Development, Inc.
|
| Amount: | $143 million
|
| Description: | Senior notes
|
| Price: | 98
|
| Placement agent: | Morgan Stanley & Co. LLC
|
| Pricing date: | Aug. 14
|
| Settlement date: | Aug. 22
|
| Distribution: | Private placement
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
